CMSC Best Practices in Multiple Sclerosis Therapies Roundtable

Article

An expert-led panel discuss the best practices and different treatment considerations in multiple sclerosis.

Related Videos
Related Content

Insights on Potential to Predict Clinical Outcomes in Optic Neuritis

September 19th 2023

Episode 92: Highlights From the 2023 CMSC, SLEEP, AHS, and ATMRD Annual Meetings

June 30th 2023

NeurologyLive® Brain Games: September 17, 2023

September 17th 2023

Generational Perspectives in Multiple Sclerosis Care

June 14th 2023

Immunodot Assay Reports High Sensitivity and Specificity for Detecting AQP4-IgG in NMOSD

September 15th 2023

Rebound Relapse Effect Identified in NMOSD Following Eculizumab Discontinuation

September 14th 2023

Insights on Potential to Predict Clinical Outcomes in Optic Neuritis

September 19th 2023

Episode 92: Highlights From the 2023 CMSC, SLEEP, AHS, and ATMRD Annual Meetings

June 30th 2023

NeurologyLive® Brain Games: September 17, 2023

September 17th 2023

Generational Perspectives in Multiple Sclerosis Care

June 14th 2023

Immunodot Assay Reports High Sensitivity and Specificity for Detecting AQP4-IgG in NMOSD

September 15th 2023

Rebound Relapse Effect Identified in NMOSD Following Eculizumab Discontinuation

September 14th 2023

Insights on Potential to Predict Clinical Outcomes in Optic Neuritis

September 19th 2023

Episode 92: Highlights From the 2023 CMSC, SLEEP, AHS, and ATMRD Annual Meetings

June 30th 2023

NeurologyLive® Brain Games: September 17, 2023

September 17th 2023

Generational Perspectives in Multiple Sclerosis Care

June 14th 2023

Immunodot Assay Reports High Sensitivity and Specificity for Detecting AQP4-IgG in NMOSD

September 15th 2023

Rebound Relapse Effect Identified in NMOSD Following Eculizumab Discontinuation

September 14th 2023
© 2023 MJH Life Sciences

All rights reserved.